36
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Biphenotypic Blast Crisis of Chronic Myelogenous Leukemia: Abnormalities of p53 and Retinoblastoma Genes

, , , , , , & show all
Pages 573-578 | Received 04 Jul 1996, Accepted 18 Jul 1996, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

ZoltÁN Beck, Attila Kiss, Ferenc D. Tóth, Judit Szabó, Attila Bácsi, ErzsÉBet Balogh, Ágnes Borbély, Béla Telek, Eszter Kovács, Éva Oláh & Kalman Rak. (2000) Alterations of P53 and RB Genes and the Evolution of the Accelerated Phase of Chronic Myeloid Leukemia. Leukemia & Lymphoma 38:5-6, pages 587-597.
Read now

Articles from other publishers (8)

Barbara J. Bain. 2017. Leukaemia Diagnosis. Leukaemia Diagnosis 371 416 .
Xueyan Chen, Joe C. Rutledge, David Wu, Min Fang, Kent E. Opheim & Min Xu. (2015) Chronic Myelogenous Leukemia Presenting in Blast Phase with Nodal, Bilineal Myeloid Sarcoma and T-Lymphoblastic Lymphoma in a Child. Pediatric and Developmental Pathology 16:2, pages 91-96.
Crossref
Barbara J. Bain. 2010. Leukaemia Diagnosis. Leukaemia Diagnosis 261 300 .
. 2007. Leukaemia Diagnosis. Leukaemia Diagnosis 180 202 .
Alison M John, N.Shaun B Thomas, Ghulam J Mufti & Rose Ann Padua. (2004) Targeted therapies in myeloid leukemia. Seminars in Cancer Biology 14:1, pages 41-62.
Crossref
Christian Sillaber, Matthias Mayerhofer, Hermine Agis, Verena Sagaster, Christine Mannhalter, Wolfgang R. Sperr, Klaus Geissler & Peter Valent. (2003) Chronic myeloid leukemia: Pathophysiology, diagnostic parameters, and current treatment conceptsChronische myeloische Leukämie: Pathophysiologie, Diagnostik und aktuelle Therapiekonzepte. Wiener Klinische Wochenschrift 115:13-14, pages 485-504.
Crossref
AS Shet, BN Jahagirdar & CM Verfaillie. (2002) Chronic myelogenous leukemia: mechanisms underlying disease progression. Leukemia 16:8, pages 1402-1411.
Crossref
Stefan FaderlMoshe TalpazZeev EstrovHagop M. Kantarjian. (1999) Chronic Myelogenous Leukemia: Biology and Therapy. Annals of Internal Medicine 131:3, pages 207.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.